Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

原文鏈接: https://www.nytimes.com/2026/03/31/business/eli-lilly-narcolepsy-centessa.html